deltatrials
Completed PHASE3 NCT00000478

Asymptomatic Cardiac Ischemia Pilot (ACIP) Study

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Cardiovascular Diseases Coronary Disease Heart Diseases Myocardial Ischemia
Interventions angioplasty, transluminal, percutaneous coronary atenolol coronary artery bypass coronary artery bypass diltiazem isosorbide dinitrate nifedipine
Updated 5 times since 2017 Last updated: Mar 24, 2016 Started: Nov 30, 1990 Completion: Jun 30, 1997

A PHASE3 clinical study on Cardiovascular Diseases and Coronary Disease, this trial is completed. The trial is conducted by National Heart, Lung, and Blood Institute (NHLBI) and has accumulated 5 data snapshots since 1990. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Nov 1990

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Heart, Lung, and Blood Institute (NHLBI)
Data source: National Heart, Lung, and Blood Institute (NHLBI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.